BPC-157
BPC-157

£19.99

Read more This product has multiple variants. The options may be chosen on the product page

BPC-157

£19.99

  • UK Stock
  • Secure Payments
  • Discreet UK Delivery

BPC-157 is a synthetic 15-amino-acid peptide supplied as a lyophilised material for cell-migration, extracellular-matrix, angiogenic-signalling and preclinical tissue-repair research.

COMPLETE YOUR KIT

Bacteriostatic Water - 3ml
Bacteriostatic Water - 3ml

In stock

£3.99
GHK-Cu - 50mg
GHK-Cu - 50mg

In stock

£19.99
1 Vial
£19.99
1 Vial
£17.99 Save 10%
3 Vials
£16.99 Save 15%
5 Vials
£15.99 Save 20%

For in vitro laboratory research only.
Not for human or veterinary use. Not for diagnosis, treatment, cure, or prevention of any disease. No dosage, administration, or injection guidance is provided.

This product is currently sold out!

No worries! Please enter your e-mail address and we will promptly notify you as soon as the item is back in stock.

Great! You have been added to the waitlist for this product. Please check your inbox and confirm the subscription to this waitlist.

BPC-157 is a synthetic 15-amino-acid peptide corresponding to the sequence GEPPPGKPADDAGLV. It is supplied as a lyophilised research material for controlled studies of cell migration, extracellular-matrix regulation, angiogenic signalling and preclinical tissue-repair models.

Research material only

This material is not supplied as an authorised medicine, treatment, supplement or consumer product. It is not for human or veterinary use, consumption or administration, and is not intended to diagnose, treat, cure or prevent any disease.

Compound overview

CompoundBPC-157
Alternative descriptionStable gastric pentadecapeptide
Research classSynthetic pentadecapeptide
Reference sequenceGEPPPGKPADDAGLV
Reference molecular massApproximately 1419.5 Da
FormLyophilised material

Research context

Published BPC-157 research has examined tendon-derived cells, endothelial signalling, angiogenesis and tissue-remodelling responses. Experimental work includes cell-culture studies and animal models investigating pathways such as VEGFR2–Akt–eNOS, nitric-oxide signalling, fibroblast activity and extracellular-matrix organisation.

The evidence base remains predominantly preclinical. Recent evidence reviews identify very limited human data and an absence of robust clinical validation. Findings from cell and animal models do not establish safety or efficacy in people and do not establish the identity, purity, performance or suitability of the material supplied on this page.

Batch documentation

Independent analytical documentation is published where available for specific batches and variations. A result indicator appears only when a published record is available. Match the product, stated mass and batch identifier to the corresponding report before relying on any result.

View available BPC-157 lab results →

Supply and laboratory handling

  • Supplied in the vial size selected above.
  • Keep the sealed lyophilised vial dry and protected from direct light.
  • A cool, dry place, refrigerator or freezer may be used according to the intended storage duration and your laboratory’s validated procedure.
  • Use clean laboratory technique and equipment appropriate to the intended analytical method.
  • Follow the lot-specific documentation and your laboratory’s validated handling and storage procedures.
  • Avoid repeated temperature cycling and unnecessary exposure to moisture.

Where a batch document or supplier specification gives different instructions, the lot-specific document takes precedence.

Frequently asked questions

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide with the reference sequence GEPPPGKPADDAGLV. It is commonly described in the literature as a stable gastric pentadecapeptide.

What type of research has examined BPC-157?

Published work includes cell and animal studies of tendon-derived cells, endothelial signalling, angiogenesis, nitric-oxide-associated pathways and tissue-remodelling models. These preclinical findings must not be interpreted as established human outcomes.

Is BPC-157 an authorised medicine?

No authorised BPC-157 medicine is supplied on this page. This product is a laboratory research material and is not for human or veterinary use, consumption or administration.

Which vial sizes are available?

Current vial sizes, stock, pre-order status, pricing and any batch-documentation indicators are shown in the variation selector above.

Does every vial size have a published laboratory result?

No. Results are available only for the selected batches and variations marked with a result indicator. Always check that the product, stated mass and batch identifier match the report.

How should the material be stored?

Keep the sealed lyophilised material dry and protected from light. A cool, dry place, refrigerator or freezer may be used according to the intended storage duration and your laboratory’s validated procedure. Avoid repeated temperature cycling and moisture exposure. No universal shelf-life is stated unless it is supported by batch documentation.

Information reviewed: 29 August 2026.

Size

10mg

Batch-specific analytical documentation

Independent analytical results are published for selected Havoc Labs products, vial sizes and batches. The result attached to one variation must not be treated as evidence for a different size or batch.

  • Result available: a published report is available for the marked variation.
  • Test pending: a sample has been submitted, but no completed result is being claimed.
  • No indicator: no product-specific result is currently displayed for that variation.

Check the identifiers

Always match the compound, vial size and batch reference on the product to the corresponding laboratory record. Where the laboratory provides an independent verification facility, use it to confirm the report.

Browse published lab results →

Storage and stability

Storage requirements can vary by compound, physical form, intended storage duration and batch. Follow the lot-specific documentation and your laboratory’s validated procedure wherever these are available.

Form Suggested storage Important note
Sealed lyophilised material Keep in a cool, dry place, refrigerated at 2–8°C or frozen, as appropriate for the compound and intended storage period. Keep sealed, dry and protected from direct light. Follow compound- and batch-specific documentation and avoid repeated temperature cycling.
Reconstituted solution Refrigerate at 2–8°C unless the applicable laboratory protocol specifies otherwise. Stability depends on the preparation conditions, solvent, concentration, container and handling. No universal storage period is claimed.

No universal shelf-life is claimed

Do not assume a fixed expiry or prepared-solution storage period unless it is supported by relevant stability data or batch documentation. Where a lot-specific document gives different instructions, that document takes precedence.

Published research

The sources below provide compound-level context for BPC-157, including its reference sequence, tendon-cell and animal models, endothelial signalling and the limitations of the current evidence base.

  1. PubChem. BPC-157 — Compound Summary, CID 9941957. Reference identifiers, sequence, formula and computed molecular mass. View on PubChem ↗
  2. Staresinic M et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research, 2003. Rat tendon and cultured-tendocyte research. View on PubMed ↗
  3. Hsieh MJ et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine, 2017. Endothelial-cell, chick-membrane and rat-model research involving VEGFR2–Akt–eNOS signalling. View on PubMed ↗
  4. Hsieh MJ et al. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Scientific Reports, 2020. Ex-vivo rat aorta and endothelial-cell signalling research. View on PubMed ↗
  5. Vasireddi N et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS Journal, 2025. Evidence review identifying 35 preclinical studies, one limited clinical study and the absence of established clinical safety data. View on PubMed ↗

Predominantly preclinical literature

The cited findings largely come from cultured cells and animal models. They do not establish safety or efficacy in humans and do not establish the identity, purity, performance or suitability of the material supplied on this page. Confirm the product, stated mass and batch identifier against the applicable analytical documentation.